Evidence Limits in BPC-157, TB-500, and Soft Tissue Research Evidence in this area can include cell studies, animal studies, pathway research, formulation testing, stability studies, pharmacokinetic research, sports medicine studies, clinical trials, rehabilitation studies, safety reviews, and patient-reported outcomes
After an initial loading regimen of 1mg three times weekly for two weeks, maintenance therapy is typically 1mg every three months for life in conditions like pernicious anaemia, or every two months if neurological involvement was present
It is advisable to start with a lower dose, such as 200 mcg
It is also heavily studied for its role in inflammation regulation and the remodeling of the extracellular matrix
Md Yusuf Shareef Reviewed by Dr